BST
BuySecond WindAI neutralBlackRock Science and Technology Trust · Financial Services · United States · $1.6B cap · $5.4M/day traded
$50.09 -0.4% · close 13 Oct · scored 14 Oct
StockRank down 1.9 since 13 Oct.
Second Wind: Cheap and rising again, but the business does not yet earn the optimism.
As of 14 Oct 2026, MoatMap's StockRank for BlackRock Science and Technology Trust (BST) is 77/100, ranked against 24,000+ stocks in 35 markets (Quality 43, Value 52, Momentum 77, each scored against its sector).
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
BlackRock Science and Technology Trust is a closed-end fund that holds a portfolio of global technology stocks and writes options on part of it to fund a high distribution. It benefits from the AI spending cycle through its holdings. However, it is a pooled vehicle rather than an operating business. It has no moat of its own, its return is the market return on tech minus fees and option overwrite drag, and it recently paid special distributions. Its value depends on the discount or premium to net asset value rather than on company economics.
ABOUT BLACKROCK SCIENCE AND TECHNOLOGY TRUST
Read
The BlackRock Science and Technology Trust is a closed-end fund managed by BlackRock, investing primarily in equity securities of both U.S. and non-U.S. companies operating in the science and technology sectors. The fund employs an options writing strategy, typically covered calls, to enhance its income generation, aiming to provide a high level of current income. BST leverages BlackRock's deep industry expertise to offer exposure to innovative tech companies combined with an income component.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | -653.3M | 291.3M | 274.2M | 252.3M | -6.9% | 252.3M |
| EPS | 5.41 | -20.29 | 8.63 | 7.86 | 7.22 | 7.5% | 15.45 |
| Shares | — | 33.0M | 34.4M | 34.7M | 34.7M | +5.2% | — |
| Debt | — | 88.1K | 0.5M | — | — | 475.3% | — |
| Equity | — | 960.7M | 1.2B | 1.4B | 1.5B | 15.5% | — |
| Op CF | — | 69.7M | 52.4M | 94.1M | 143.3M | 27.2% | 143.3M |
| Inv CF | — | — | — | — | — | — | — |
| Fin CF | — | -68.9M | -54.6M | -94.5M | -143.4M | — | — |
Above its 200-day average and 4% below its 52-week high.
Calmer than 86% of stocks we rank over the past year (23% a year).
How this is worked out
StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.
The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of BST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BST | BlackRock Science and Technology Trust(you) | $1.6B | 77 | Buy |
| TY | Tri-Continental Corporation | $1.8B | 77 | Buy |
| TRIN | Trinity Capital Inc. | $1.6B | 72 | Buy |
| NFJ | Virtus Dividend, Interest & Premium Strategy Fund | $1.4B | 80 | Buy |
| BSTZ | BlackRock Science and Technology Term Trust | $2.0B | 74 | Buy |
| CSWC | Capital Southwest Corporation | $1.5B | 68 | Buy |
| ETG | Eaton Vance Tax-Advantaged Global Dividend Income Fund | $1.8B | 85 | Strong Buy |
| BBDC | Barings BDC, Inc. | $907M | 76 | Buy |
| APAM | Artisan Partners Asset Management Inc. | $2.5B | 73 | Buy |
| WWH.L | Worldwide Healthcare Ord | $1.7B | 65 | Buy |
Peer medians: ROE 9.7% · P/E 12.4x · Gross margin 100.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.